Clinical Trials Browser

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

NCT02023710 2017-05-09

Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

Phase 2 Unknown

182 enrolled

Dermatologic

Melanoma

NCT00976573 2017-04-04

Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

149 enrolled 9 charts

Dermatologic

Melanoma

NCT01200342 2016-02-11

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Phase 2 Terminated

7 enrolled 3 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT00984464 2015-04-10

Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Phase 2 Completed

14 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT00329641 2014-07-31

Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye

Phase 2 Completed

25 enrolled 6 charts

Dermatologic

Uveal Melanoma

NCT01014351 2014-03-26

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Phase 2 Completed

70 enrolled 8 charts

Dermatologic

Melanoma

NCT00255762 2013-10-28

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

47 enrolled

Dermatologic

Melanoma

NCT00288041 2013-03-05

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Phase 2 Completed

36 enrolled

Dermatologic

Uveal Melanoma, Melanoma

Clinical Trials

A Phase II Trial of LM103 in Advanced Melanoma

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

PANDORA

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

KEYNOTE 002

Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

BEAM

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma